Related Experiment Video
Updated: Mar 31, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer
Mei Chee Tai, Taisuke Kajino, Masahiro Nakatochi1
1Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
Abstract:
Accumulating evidence indicates that altered miRNA expression is crucially involved in lung cancer development, though scant information is available regarding how MYC, an archetypical oncogene, is regulated by miRNAs, especially via a mechanism involving MYC cofactors. In this study, we attempted to identify miRNAs involved in regulation of MYC transcriptional activity in lung cancer. To this end, we utilized an integrative approach with combinatorial usage of miRNA and mRNA expression profile datasets of patient tumor tissues, as well as those of MYC-inducible cell lines in vitro. In addition to miRNAs previously reported to be directly regulated by MYC, including let-7 and miR-17-92, our strategy also helped to identify miR-342-3p as capable of indirectly regulating MYC activity via direct repression of E2F1, a MYC-cooperating molecule. Furthermore, miR-342-3p module activity, which we defined as a gene set reflecting the experimentally substantiated influence of miR-342-3p on mRNA expression, was found to be inversely correlated with MYC activity reflected by MYC module activity in three independent datasets of lung adenocarcinoma patients obtained from the Director's Challenge Consortium of the United States (P = 1.94 × 10(-73)), the National Cancer Center of Japan (P = 9.05 × 10(-34)) and the present study (P = 1.17 × 10(-19)). Our integrative approach appears to be useful to elucidate inter-regulatory relationships between miRNAs and protein coding genes of interest, even those present in patient tumor tissues, which remains a challenge to better understand the pathogenesis of this devastating disease.
Insights
This study identifies microRNAs (miRNAs) regulating the oncogene MYC in lung cancer. It found miR-342-3p indirectly controls MYC by targeting E2F1, revealing a new regulatory pathway in lung adenocarcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Altered microRNA (miRNA) expression is implicated in lung cancer pathogenesis.
- The regulation of the oncogene MYC by miRNAs, particularly through cofactors, is not well understood.
Purpose of the Study:
- To identify miRNAs involved in regulating MYC transcriptional activity in lung cancer.
- To explore the inter-regulatory relationships between miRNAs and protein-coding genes in lung cancer pathogenesis.
Main Methods:
- Utilized an integrative approach combining miRNA and mRNA expression profile datasets from patient tumor tissues and MYC-inducible cell lines.
- Analyzed miRNA and MYC module activity correlations in independent lung adenocarcinoma patient datasets.
Main Results:
- Identified miR-342-3p as an indirect regulator of MYC activity by repressing E2F1, a MYC-cooperating molecule.
- Demonstrated an inverse correlation between miR-342-3p module activity and MYC module activity in lung adenocarcinoma patient datasets.
- Confirmed previously known MYC-regulated miRNAs (let-7, miR-17-92) and identified novel regulatory interactions.
Conclusions:
- The study elucidates a novel indirect regulatory mechanism of MYC by miR-342-3p in lung cancer.
- The integrative approach is effective for uncovering miRNA-gene inter-regulatory networks in patient tumor tissues.
- Findings contribute to understanding lung cancer pathogenesis and may offer new therapeutic targets.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
MicroRNAs
MicroRNAs
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

